Hansen BV - Search Results

1

Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study.

Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH. Rossing K, et al. Among authors: hansen bv. Diabetes Care. 2003 Jan;26(1):150-5. doi: 10.2337/diacare.26.1.150. Diabetes Care. 2003. PMID: 12502672 Clinical Trial.

2

Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

Jacobsen P, Andersen S, Rossing K, Hansen BV, Parving HH. Jacobsen P, et al. Among authors: hansen bv. Nephrol Dial Transplant. 2002 Jun;17(6):1019-24. doi: 10.1093/ndt/17.6.1019. Nephrol Dial Transplant. 2002. PMID: 12032191 Clinical Trial.

3

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Astrup AS, et al. Among authors: hansen bv. Diabetes Care. 2006 Feb;29(2):334-9. doi: 10.2337/diacare.29.02.06.dc05-1242. Diabetes Care. 2006. PMID: 16443883

4

Low birth weight. A risk factor for development of diabetic nephropathy?

Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH. Rossing P, et al. Among authors: hansen bv. Diabetes. 1995 Dec;44(12):1405-7. doi: 10.2337/diab.44.12.1405. Diabetes. 1995. PMID: 7589846

5

Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.

Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH. Tarnow L, et al. Among authors: hansen bv. Diabetes. 1995 May;44(5):489-94. doi: 10.2337/diab.44.5.489. Diabetes. 1995. PMID: 7729604

6

Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy.

Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving HH. Tarnow L, et al. Among authors: hansen bv. Diabetes. 1996 Mar;45(3):367-369. doi: 10.2337/diab.45.3.367. Diabetes. 1996. PMID: 8593944

7

Fish oil in diabetic nephropathy.

Rossing P, Hansen BV, Nielsen FS, Myrup B, Hølmer G, Parving HH. Rossing P, et al. Among authors: hansen bv. Diabetes Care. 1996 Nov;19(11):1214-9. doi: 10.2337/diacare.19.11.1214. Diabetes Care. 1996. PMID: 8908382 Clinical Trial.

8

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH. Tarnow L, et al. Among authors: hansen bv. Diabetes Care. 1996 Dec;19(12):1382-7. doi: 10.2337/diacare.19.12.1382. Diabetes Care. 1996. PMID: 8941468

9

Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM.

Tarnow L, Pociot F, Hansen PM, Rossing P, Nielsen FS, Hansen BV, Parving HH. Tarnow L, et al. Among authors: hansen bv, hansen pm. Diabetes. 1997 Jun;46(6):1075-6. doi: 10.2337/diab.46.6.1075. Diabetes. 1997. PMID: 9166682 No abstract available.

10

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Andersen S, et al. Among authors: hansen bv. Kidney Int. 2000 Feb;57(2):601-6. doi: 10.1046/j.1523-1755.2000.00880.x. Kidney Int. 2000. PMID: 10652037 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters